INS and type 2 diabetes mellitus: The effect of sulfonylureas (SNU) and insulin on bones is thought to be neutral; although, it has been reported that insulin treatment indirectly affects bone outcomes by increasing the frequency of falls related to hypoglycaemia in elderly T2DM diabetic patients [32].